Aponia Laboratories
The business, the turning points, and the decisions behind them.
Some sections are still being researched1 / 4
Sections to complete：02
01 / WHAT IT BUILT
What the company did
Prescription products for pain relief.
02 / FAILURE REASONS
Material for this section is being gathered and checked. It will appear here once ready.
03 / EVENT HISTORY
Events in the structured record
- Company founded
Aponia Laboratories, Inc. is founded in Greenwich, Connecticut by Robert Boolbol, M.D. and Kenneth Corroon to develop and introduce safe, ibuprofen-based pain relief products; it goes on to hold 41 patents.
- Clinical trial
The company's first clinical trial (NCT02324985) begins in 2015; it also raises about $1.17 million in venture equity that year, following earlier rounds of $460,000 in 2012 and $1 million in 2013.
04 / CONTEMPORARY REBUILD ASSESSMENT
Difficulty of rebuilding this project today
Material for this section is being gathered and checked. It will appear here once ready.
Overall assessment: Not completed
05 / CAUSAL CHAIN
How the factors connect
- 01
Drug-pipeline databases list Aponia's dexibuprofen program (for myalgia) as 'Discontinued'; no shutdown announcement or acquisition of the company was found.